Western blots show that Cldn3 and Cldn4 levels are higher in metastatic prostate cancer cells (PC3, LNCaP, and DU145) compared to normal prostate cells (RWPE-1) (Fig. 1a). This evidence concerns the gene CLDN4 and prostate cancer.